Clinical Trial Detail

NCT ID NCT03389477
Title Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

oropharynx cancer

hypopharynx cancer

laryngeal squamous cell carcinoma

oral cavity cancer

Therapies

Cisplatin + Palbociclib

Cetuximab + Palbociclib

Age Groups: senior adult

Additional content available in CKB BOOST